...Gilead Sciences Inc. (NASDAQ:GILD) have NY-ESO-targeting TCR therapies in Phase II testing for solid tumors; PersonGen Biomedicine...

...cell line, cord blood or peripheral blood mononuclear cells (PBMCs) without selection for education level. PersonGen Biomedicine...

...cells (aNK cells) Allogeneic activated NK cells Phase II Merkel cell carcinoma CARs; antibody receptors PersonGen Biomedicine...
...Hospital Frankfurt started a Phase I trial of a HER2-targeted CAR-NK cell in glioblastoma patients. PersonGen Biomedicine...
...Diego, Calif. Nkarta Inc., South San Francisco, Calif. OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), Redwood City, Calif. PersonGen Biomedicine...